Chronic Rhinosinusitis Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
LYRA | F | Lyra Therapeutics, Inc. | -2.86 | |
OPTN | F | OptiNose, Inc. | -0.48 | |
CNTB | D | Connect Biopharma Holdings Limited | -0.75 |
Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
DWAS | D | PowerShares DWA SmallCap Technical Leaders Portfolio | 0.02 | |
IWC | D | iShares Microcap ETF | 0.02 | |
VTWG | B | Vanguard Russell 2000 Growth ETF | 0.01 | |
IWO | B | iShares Russell 2000 Growth ETF | 0.01 | |
VTI | A | Vanguard Total Stock Market ETF | 0.0 |
Compare ETFs
Related Industries:
Biotechnology
Drug Manufacturers - Specialty & Generic
- Chronic Rhinosinusitis
Chronic rhinosinusitis (CRS) is a long-term inflammation of the nasal passages and sinuses. It is a common condition that affects millions of people worldwide. Symptoms of CRS include nasal congestion, facial pain, postnasal drip, and a decreased sense of smell. Treatment options include medications, nasal irrigation, and surgery.
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles